Table 1.
Clinicopathologic characteristics of 94 HER2-positive luminal B breast cancer patients’.
| Characteristics | No. of patients (%) |
|---|---|
| Age (years) | |
| Median (range) | 49 (25–75) |
| Menopausal status | |
| Pre-menopause | 52 (55.3) |
| Post-menopause | 41 (43.6) |
| N/A | 1 (1.1) |
| Histologic type | |
| IDC | 90 (95.7) |
| ILC | 1 (1.1) |
| Mucinous carcinoma | 2 (2.1) |
| Micropapillary carcinoma | 1 (1.1) |
| T-stage | |
| 1 | 43 (45.7) |
| 2 | 48 (51.1) |
| 3 | 3 (3.2) |
| N stage | |
| 0 | 50 (53.8) |
| 1 | 28 (30.1) |
| 2 | 12 (12.9) |
| 3 | 3 (3.2) |
| N/A | 1 (1.1) |
| Stage | |
| I | 32 (34.0) |
| II | 45 (47.9) |
| III | 16 (17.1) |
| IV | 1 (1.1) |
| Histologic grade | |
| I | 2 (2.1) |
| II | 33 (35.1) |
| III | 59 (62.8) |
| Herceptin Tx | |
| Yes | 72 (76.6) |
| No | 17 (18.1) |
| NA | 5 (5.3) |
| Chemo Tx | |
| Yes | 80 (85.1) |
| No | 9 (9.6) |
| NA | 5 (5.3) |
| Hormonal Tx | |
| Yes | 72 (76.6) |
| No | 17 (18.1) |
| NA | 5 (5.3) |
| Radiation Tx | |
| Yes | 77 (81.9) |
| No | 12 (12.8) |
| NA | 5 (5.3) |
| Recur | |
| Yes | 8 (8.5) |
| No | 81 (86.2) |
| NA | 5 (5.3) |